KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Dividends Paid - Common (2020 - 2025)

Historic Dividends Paid - Common for Evolent Health (EVH) over the last 6 years, with Q3 2025 value amounting to $1.9 million.

  • Evolent Health's Dividends Paid - Common fell 6242.7% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.9 million, marking a year-over-year decrease of 2205.37%. This contributed to the annual value of $20.1 million for FY2024, which is 687.49% up from last year.
  • Evolent Health's Dividends Paid - Common amounted to $1.9 million in Q3 2025, which was down 6242.7% from $4.6 million recorded in Q2 2025.
  • Evolent Health's 5-year Dividends Paid - Common high stood at $13.8 million for Q2 2022, and its period low was $1.1 million during Q1 2022.
  • Over the past 5 years, Evolent Health's median Dividends Paid - Common value was $4.8 million (recorded in 2023), while the average stood at $4.7 million.
  • Per our database at Business Quant, Evolent Health's Dividends Paid - Common surged by 96030.77% in 2022 and then crashed by 6456.76% in 2023.
  • Quarter analysis of 5 years shows Evolent Health's Dividends Paid - Common stood at $1.3 million in 2021, then soared by 960.31% to $13.8 million in 2022, then plummeted by 62.55% to $5.2 million in 2023, then dropped by 6.9% to $4.8 million in 2024, then plummeted by 59.86% to $1.9 million in 2025.
  • Its Dividends Paid - Common stands at $1.9 million for Q3 2025, versus $4.6 million for Q2 2025 and $4.6 million for Q1 2025.